Lo nuevo en EM: Navegando por un nuevo diagnóstico

Lo nuevo en EM: A dónde ir desde aquí

Presentado por Dr. Fernando Cuascut, MD, MPH “Lo nuevo en EM: A dónde ir desde aquí” es la tercera entrega de la serie Viviendo fuerte con Esclerosis Múltiple. Únase al Dr. Fernando Cuascut, especialista en EM y con Maestría en Salud Pública, ya que comparte importantes herramientas y consejos del experto para personas diagnosticadas recientemente […]

Read News Article
Stretch and Strengthen

Stretch and Strengthen

Featuring Gwynne Jones, DPT, MSCS Join holistic-minded physical therapist, Dr. Gwynne Jones, for an interactive program which includes tips for safe lifting and support transfers, as well as sample exercises that physical therapists might use to help address balance and stability. For a transcript of this program, please click here. For a list of activities […]

Read News Article
Living Rural 2

Rural Perspectives on Living with MS

Featuring Brant Oliver, PhD, MS, MPH, FNP-BC, PMHNP-BC; E. Chandlee Bryan; and Rayna Kenney Living in a rural or an underserved area presents unique challenges to people living with MS. In this second program in our “Living Rural with MS” listen in on a panel discussion regarding these challenges and potential solutions. For a transcript […]

Read News Article

Introducing, Selma Blair Documentary Discussion Guide Now Available

We invite the MS community to watch Selma Blair’s award-winning documentary Introducing, Selma Blair now available for streaming on Discovery+. In the film, Ms. Blair shares her experiences and challenges with multiple sclerosis and provides an inside view of her journey of personal acceptance and resilience after being diagnosed with MS.  Viewers are also encouraged to access […]

Read News Article

What’s New in MS Research – November 2021

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD In this Article More evidence on the benefits of starting DMTs sooner rather than later Assessing the impact of Ocrevus® on patients with early-stage relapsing-remitting MS Investigational agent ublituximab lowers relapse rate in two Phase III studies Study details tolebrutinib efficacy, safety profile over 48 […]

Read News Article